Publicacións nas que colabora con María Luisa Lozano Almela (12)

2024

  1. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

    Blood, Vol. 144, Núm. 6, pp. 646-656

2021

  1. A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients

    Blood Cells, Molecules, and Diseases, Vol. 86

  2. Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (Scientific Reports, (2019), 9, 1, (16680), 10.1038/s41598-019-53209-y)

    Scientific Reports

  3. Expanding the genetic spectrum of TUBB1-related thrombocytopenia

    Blood Advances, Vol. 5, Núm. 24, pp. 5453-5467

2020

  1. Retrospective Multicenter Study of Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic Graft-versus-Host Disease

    Biology of Blood and Marrow Transplantation, Vol. 26, Núm. 4, pp. 651-658

2019

  1. Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia

    Scientific Reports, Vol. 9, Núm. 1

  2. Management of adult patients with primary immune thrombocytopenia (itp) in clinical practice: A consensus approach of the Spanish itp expert group

    Advances in Hematology, Vol. 2019

2018

  1. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders

    Haematologica, Vol. 103, Núm. 1, pp. 148-162

2014

  1. Functional and molecular characterization of inherited platelet disorders in the Iberian Peninsula: Results from a collaborative study

    Orphanet Journal of Rare Diseases, Vol. 9, Núm. 1

2004

  1. Trasplante de progenitores hematopoyéticos de sangre periférica en España: Análisis de coste

    Medicina Clinica, Vol. 123, Núm. 11, pp. 401-405

2000

  1. Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF

    Bone Marrow Transplantation, Vol. 25, Núm. 3, pp. 231-235

  2. Re-mobilization of peripheral blood progenitor cells within a short time interval fails to achieve effective progenitor cell yields

    Bone Marrow Transplantation, Vol. 26, Núm. 3, pp. 351-352